Article Details

Pfizer plans $120m investment for Covid-19 oral drug manufacturing in US

Retrieved on: 2022-06-07 16:34:15

Tags for this article:

Click the tags to see associated articles and topics

Pfizer plans $120m investment for Covid-19 oral drug manufacturing in US. View article details on HISWAI: https://www.pharmaceutical-technology.com/news/pfizer-120m-investment-covid-19-oral-drug/

Excerpt

Pfizer has announced plans to invest $120m in its manufacturing facility in Kalamazoo, Michigan, US, to produce Paxlovid.

Article found on: www.pharmaceutical-technology.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up